Lailton Oliveira da Silva 1 * , Victor Da Silva 2 , Anderson Weiny Barbalho Silva 3 , José Juvenal Linhares 4
Correspondence: lailtonutri@hotmail.com
DOI: https://doi.org/10.55976/fnds.22024124666-75
Show More
[1]IARC [Internet]. Estimated number of deaths in 2020, Word. Available from https://gco.iarc.fr/today/home. [Accessed 24th Jul 2023].
[2]ACS [internet]. Dietary Supplements, 2021. Available from https://www.cancer.org/cancer/managing-cancer/treatment-types/complementary-and-integrative-medicine/dietary-supplements.html [Accessed 25th Jul 2023].
[3]Carlberg C, Muñoz A. An update on vitamin D signaling and cancer. Seminars in Cancer Biology. 2022; 79: 217-230. doi: 10.1016/j.semcancer.2020.05.018.
[4]Carlberg C, Velleuer E. Vitamin D and the risk for cancer: A molecular analysis. Biochem Pharmacol. 2022; 196: 114735. doi: 10.1016/j.bcp.2021.114735.
[5]Saini RK, Prasad P, Sreedhar RV, et al. Omega-3 Polyunsaturated Fatty Acids (PUFAs): Emerging Plant and Microbial Sources, Oxidative Stability, Bioavailability, and Health Benefits-A Review. Antioxidants (Basel). 2021; 10: 1627-1636. doi: 10.3390/antiox10101627.
[6]Redruello-Requejo M, Samaniego-Vaesken ML, Puga AM, et al. Intake, Determinants and Dietary Sources of Omega-3 and Omega-6 Polyunsaturated Fatty Acids in the Spanish Population: Study Results ANIBES. Nutrientes. 2023; 15: 562-571. doi: 10.3390/nu15030562.
[7]Vega OM, Abkenari S, Tong Z, et al. Omega-3 Polyunsaturated Fatty Acids and Lung Cancer: nutrition or Pharmacology? Nutrition and Cancer. 2021; 73: 541-561. doi: 10.1080/01635581.2020.1761408.
[8]Fabian CJ, Kimler BF, Hursting SD. Omega-3 fatty acids for breast cancer prevention and survivorship. Breast Cancer Research. 2015; 17: 62-73. doi: 10.1186/s13058-015-0571-6.
[9]Pizato N, Luzete BC, Kiffer LFMV, et al. Omega-3 docosahexaenoic acid induces pyroptosis cell death in triple-negative breast cancer cells. Scientific Reports. 2018; 8: 1952-1964. doi: 10.1038/s41598-018-20422-0.
[10]Benedik E. Sources of vitamin D for humans. International Journal for Vitamin and Nutrition Research. 2022; 92: 118-125. doi: 10.1024/0300-9831/a000733.
[11]Wang W, Hu W, Xue S, et al. Vitamin D and Lung Cancer; Association, Prevention, and Treatment. Nutrition and Cancer. 2021; 73: 2188-2200. doi: 10.1080/01635581.2020.1844245.
[12]Martin-Gorgojo A, Gilaberte Y, Nagore E. Vitamin D and Skin Cancer: An Epidemiological, Patient-Centered Update and Review. Nutrients. 2021; 13: 4292-4306. doi: 10.3390/nu13124292.
[13]Vanhevel J, Verlinden L, Doms S, et al. The role of vitamin D in breast cancer risk and progression. Endocrine-Related Cancer. 2022; 29: R33-R55. doi: 10.1530/ERC-21-0182.
[14]Lee KH, Seong HJ, Kim G, et al. Consumption of Fish and ω-3 Fatty Acids and Cancer Risk: An Umbrella Review of Meta-Analyses of Observational Studies. Advances in Nutrition. 2020; 11: 1134-1149. doi: 10.1093/advances/nmaa055.
[15]Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. International Journal of Surgery. 2021; 88:105906. doi: 10.1016/j.ijsu.2021.105906.
[16]Paixão EMDS, Oliveira ACM, Pizato N, et al. The effects of EPA and DHA enriched fish oil on nutritional and immunological markers of treatment naïve breast cancer patients: a randomized double-blind controlled trial. Nutrition Journal. 2017; 16: 71-82. doi: 10.1186/s12937-017-0295-9.
[17]De La Rosa Oliva F, Meneses García A, Ruiz Calzada H, et al. Effects of omega-3 fatty acids supplementation on neoadjuvant chemotherapy-induced toxicity in patients with locally advanced breast cancer: a randomized, controlled, double-blinded clinical trial. Nutricion Hospitalaria. 2019; 36: 769-776. doi: 10.20960/nh.2338.
[18]Darwito D, Dharmana E, Riwanto I, et al. Effects of Omega-3 Supplementation on Ki-67 and VEGF Expression Levels and Clinical Outcomes of Locally Advanced Breast Cancer Patients Treated with Neoadjuvant CAF Chemotherapy: A Randomized Controlled Trial Report. Asian Pacific Journal of Cancer Prevention. 2019; 20: 911-916. doi: 10.31557%2FAPJCP.2019.20.3.911.
[19]Peppone LJ, Inglis JE, Mustian KM, et al. Multicenter randomized controlled trial of omega-3 fatty acids versus omega-6 fatty acids for the control of cancer-related fatigue among breast cancer survivors. JNCI Cancer Spectrum. 2019; 3: pkz005. doi: 10.1093/jncics/pkz005.
[20]Mohseni H, Amani R, Hosseini SA, et al. Genetic Variations in VDR Could Modulate the Efficacy of Vitamin D3 Supplementation on Inflammatory Markers and Total Antioxidant Capacity among Breast Cancer Women: A Randomized Double-Blind Controlled Trial. Asian Pacific Journal of Cancer Prevention. 2019; 20: 2065-2072. doi: 10.31557%2FAPJCP.2019.20.7.2065.
[21]El-Bassiouny NA, Helmy MW, Hassan MAE, et al. The cardioprotective effect of vitamin D in breast cancer patients receiving adjuvant doxorubicin-based chemotherapy. Clinical Breast Cancer. 2022; 22: 359-366. doi: 10.1016/j.clbc.2022.01.008.
[22]Going CC, Alexandrova L, Lau K, et al. Vitamin D supplementation decreases serum 27-hydroxycholesterol and expression of CYP27A1 in tumors of breast cancer patients. Cancer Research. 2017; 77: 5635-5635. doi:10.1158/1538-7445.AM2017-5635.
[23]D'Angelo S, Motti ML, Meccariello R. ω-3 and ω-6 Polyunsaturated Fatty Acids, Obesity and Cancer. Nutrients. 2020; 12: 2751-2767. doi: 10.3390/nu12092751.
[24]Podpeskar A, Crazzolara R, Kropshofer G, et al. Omega-3 Fatty Acids and Their Role in Pediatric Cancer. Nutrients. 2021; 13: 1800-1813. doi: 10.3390/nu13061800.
[25]Aredes MA, da Camara AO, de Paula NS, et al. Efficacy of ω-3 supplementation on nutritional status, skeletal muscle, and chemoradiotherapy toxicity in cervical cancer patients: A randomized, triple-blind, clinical trial conducted in a middle-income country. Nutrition. 2019; 67: 110528. doi: 10.1016/j.nut.2019.06.009.
[26]Lee KH, Seong HJ, Kim G, et al. Consumption of Fish and ω-3 Fatty Acids and Cancer Risk: An Umbrella Review of Meta-Analyses of Observational Studies. Advances in Nutrition. 2020; 11: 1134-1149. doi: 10.1093/advances/nmaa055.
[27]De Abreu Leite JT, Lobo LC, De Andrade LG. Ômega-3 no tratamento paliativo do câncer. Revista Ibero-Americana de Humanidades, Ciências e Educação. 2021; 7: 1547-1561. doi: 10.51891/rease.v7i10.2680.
[28]Gomes ALM, Magalhães JA, Neves JP, et al. Efeitos da suplementação de arginina, glutamina e ômega-3 sobre a resposta inflamatória e estado nutricional de pacientes oncológicos. Research, Society and Development. 2020; 9: e193953285-e193953285. doi: 10.33448/rsd-v9i5.3285.
[29]Hutchins-Wiese HL, Picho K, Watkins BA, et al. High-dose eicosapentaenoic acid and docosahexaenoic acid supplementation reduces bone resorption in postmenopausal breast cancer survivors on aromatase inhibitors: a pilot study. Nutrition and Cancer. 2014; 66: 68-76. doi: 10.1080/01635581.2014.847964.
[30]Laudisio D, Castellucci B, Barrea L, et al. Mediterranean diet and breast cancer risk: a narrative review. Minerva Endocrinol (Torino). 2021; 46: 441-452. doi: 10.23736/s2724-6507.20.03266-6.
[31]Shen S, Unger JM, Crew KD, et al. Omega-3 fatty acid use for obese breast cancer patients with aromatase inhibitor-related arthralgia (SWOG S0927). Breast Cancer Research and Treatment. 2018; 172: 603-610. doi:10.1007%2Fs10549-018-4946-0.
[32]Hershman DL, Unger JM, Crew KD, et al. Randomized Multicenter Placebo-Controlled Trial of Omega-3 Fatty Acids for the Control of Aromatase Inhibitor–Induced Musculoskeletal Pain: SWOG S0927. Journal of Clinical Oncology. 2015; 33: 1910-1917. doi: 10.1200/jco.2014.59.5595.
[33]Lustberg MB, Orchard TS, Reinbolt R, et al. Randomized placebo-controlled pilot trial of omega 3 fatty acids for prevention of aromatase inhibitor-induced musculoskeletal pain. Breast Cancer Research and Treatment. 2018; 167: 709-718. doi: 10.1007/s10549-017-4559-z.
[34]Hutchins-Wiese HL, Picho K, Watkins BA, et al. High-Dose Eicosapentaenoic Acid and Docosahexaenoic Acid Supplementation Reduce Bone Resorption in Postmenopausal Breast Cancer Survivors on Aromatase Inhibitors: A Pilot Study. Nutrition and Cancer. 2014; 66: 68-76. doi: 10.1080/01635581.2014.847964.
[35]Silva LO, Sousa IML, Paim RTT, et al. Perfil nutricional e consumo alimentar de pacientes com câncer de mama: uma revisão integrativa. RBONE. 2023;17:185-91.
[36]Turati F, Carioli G, Bravi F, et al. Mediterranean Diet and Breast Cancer Risk. Nutrients. 2018; 10: 326-339. doi: 10.3390/nu10030326.
[37]Van Den Brandt PA, Schulpen M. Mediterranean diet adherence and risk of postmenopausal breast cancer: results of a cohort study and meta-analysis. International Journal of Cancer. 2017;140:2220-2231. doi: 10.1002/ijc.30654.
[38]Butler LM, Wu AH, Wang R, et al. A vegetable-fruit-soy dietary pattern protects against breast cancer among postmenopausal Singapore Chinese women. The American Journal of Clinical Nutrition. 2010; 91: 1013-1019. doi: 10.3945/ajcn.2009.28572.
[39]Rosso C, Fera N, Murugan NJ, et al. Vitamin D Levels in Newly Diagnosed Breast Cancer Patients According to Tumor Sub-Types. Journal of Dietary Supplements. 2022; 14: 1-13. doi: 10.1080/19390211.2022.2144582.
[40]Bakhshaiesh TO, Nazeri E, Jafarbeik-Iravani N, et al. Vitamin D and breast cancer risk: A systematic review and meta-analysis in Iranian patients. Annals of Medicine and Surgery (Lond). 2022; 80: 104162. doi: 10.1016/j.amsu.2022.104162.
[41]Fernandes EMA, Linhares JJ. Papel dos níveis séricos de vitamina d e da síndrome metabólica e o risco de câncer de mama. Arquivos Catarinenses de Medicina. 2021; 50: 257-70.
[42]Isbilen E, Kus T, Cinkir HY, et al. Better survival associated with successful vitamin D supplementation in non-metastatic breast cancer survivors. Turkish Journal of Biochemistry. 2021; 46: 509-516. doi: 10.1515/tjb-2021-0137.
[43]Zhang X, Harbeck N, Jeschke U, et al. Influence of vitamin D signaling on hormone receptor status and HER2 expression in breast cancer. Journal of Cancer Research and Clinical Oncology. 2017; 143: 1107-1122. doi: 10.1007/s00432-016-2325-y.
[44]Li Z, Wu L, Zhang J, et al. Effect of vitamin D supplementation on risk of breast cancer: a systematic review and meta-analysis of randomized controlled trials. Frontiers in Nutrition. 2021; 8: 655727. doi: 10.3389/fnut.2021.655727.
[45]Huss L, Butt ST, Borgquist S, et al. Vitamin D receptor expression in invasive breast tumors and breast cancer survival. Breast Cancer Research. 2019; 21: 84. doi: 10.1186/s13058-019-1169-1.
[46]Cui X, Pertile R, Eyles DW. The vitamin D receptor (VDR) binds to the nuclear matrix via its hinge domain: a potential mechanism for the reduction in VDR-mediated transcription in mitotic cells. Molecular and Cellular Endocrinology. 2018; 472:18-25. doi: 10.1016/j.mce.2017.11.015.
[47]Trivedi T, Zheng Y, Fournier PGJ, et al. The vitamin D receptor is involved in the regulation of human breast cancer cell growth via a ligand-independent function in the cytoplasm. Oncotarget. 2017; (8)16: 26687. doi: 10.18632/oncotarget.15803.
Copyright © 2024 Lailton Oliveira da Silva, Victor Da Silva, Anderson Weiny Barbalho Silva, José Juvenal Linhares
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright licenses detail the rights for publication, distribution, and use of research. Open Access articles published by Luminescience do not require transfer of copyright, as the copyright remains with the author. In opting for open access, the author(s) should agree to publish the article under the CC BY license (Creative Commons Attribution 4.0 International License). The CC BY license allows for maximum dissemination and re-use of open access materials and is preferred by many research funding bodies. Under this license, users are free to share (copy, distribute and transmit) and remix (adapt) the contribution, including for commercial purposes, providing they attribute the contribution in the manner specified by the author or licensor.
Luminescience press is based in Hong Kong with offices in Wuhan and Xi'an, China.
E-mail: publisher@luminescience.cn